The safety and efficacy of high-dose chromium - High-Dose Chromium

Alternative Medicine Review, June, 2002 by Davis W. Lamson, Steven M. Plaza

(40.) Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18:860-862.

(41.) Wasser WG, Feldman NS, D'Agati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997;126:410.

(42.) Cerulli J, Grabe DW, Gauthier I, et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-431.

(43.) Fowler JF Jr. Systemic contact dermatitis caused by oral chromium picolinate. Cutis 2000;65:116.

(44.) Huszonek J. Over-the-counter chromium picolinate. Am J Psychiatry 1993;150:1560-1561.

(45.) Anderson RA, Bryden NA, Polansky MM. Lack of toxicity of chromium chloride and chromium picolinate in rats. J Am Coll Nutr 1997;16:273-279.

(46.) Esber H, Moreno V. Evaluation of chromium picolinate in the rat in vivo chromosomal aberration assay. Environ Mol Mutagen 1997;29:15.

(47.) Akatusuka K, Fairhall LT. The toxicology of chromium. J Ind Hyg 1934;16:1-24.

(48.) Ivankovic S, Preussman R. Absence of toxic and carcinogenic effects after administration of high doses of chromic oxide pigment in subacute and long-term feeding experiments in rats. Food Cosmet Toxicol 1975;13:347-351.

(49.) MacKenzie R, Byerrum R, Decker C, et al. Chronic toxicity studies II. Hexavalent and trivalent chromium administered in drinking water to rats. AMA Arch Ind Health 1958;18:232-234.

(50.) National Institutes of Health (U.S.). TRI Toxic Chemical Release Inventory: Coming Spring 1989; Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health; 1989.

(51.) Bryson WG, Goodall CM. Differential toxicity and clearance kinetics of chromium (III) or (VI) in mice. Carcinogenesis 1983;4:1535-1539.

(52.) De Flora S, Bagnasco M, Serra D, Zanacchi P. Genotoxicity of chromium compounds. A review. Mutat Res 1990;238:99-172.

(53.) Stearns DM, Belbruno JJ, Wetterhahn KE. A prediction of chromium (III) accumulation in humans from chromium dietary supplements. FASEB J 1995;9:1650-1657.

(54.) Stearns DM, Wise JP Sr, Patierno SR, Wetterhahn KE. Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J 1995;9:1643-1648.

(55.) Speetjens JK, Collins RA, Vincent JB, Woski SA. The nutritional supplement chromium (III) tris(picolinate) cleaves DNA. Chem Res Toxicol 1999;12:483-487.

(56.) Gammelgaard B, Jensen K, Steffansen B. In vitro metabolism and permeation studies in rat jejunum: organic chromium compared to inorganic chromium. J Trace Elem Med Biol 1999;13:82-88.

(57.) Vincent JB. Elucidating a biological role for chromium at a molecular level. Ace Chem Res 2000;33:503-510.

(58.) Tsou TC, Yang JL. Formation of reactive oxygen species and DNA strand breakage during interaction of chromium (III) and hydrogen peroxide in vitro: evidence for a chromium (III)-mediated Fenton-like reaction. Chem Biol Interact 1996:102:133-153.

(59.) Tsou TC, Chen CL, Liu TY, Yang JL. Induction of 8-hydroxydeoxyguanosine in DNA by chromium (Ill) plus hydrogen peroxide and its prevention by scavengers. Carcinogenesis 1996;17:103-108.